Washington, DC: In response to the Food and Drug Administration's recent approval of Apretude (cabotegravir extended-release injectable suspension) for prevention of HIV and the robust pipeline of additional long-acting antiretroviral agents currently under development, the American Academy of HIV Medicine is pleased to announce it...
Washington, DC: The American Academy of HIV Medicine, the nation’s largest independent HIV care provider organization, today commended the Biden Administration for releasing an updated National HIV/AIDS Strategy (NHAS), which renews the goal of ending the epidemic by 2030. President Biden unveiled the new plan...
Washington, DC: The American Academy of HIV Medicine, the nation’s leading non-profit representing frontline HIV care providers, warns that recent threats to the savings generated by the Federal 340B Drug Pricing Program will compromise access to affordable care, treatment and prevention services for underserved people...
Washington, DC: The American Academy of HIV Medicine today extended its support to the newly introduced bipartisan Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act (H.R. 5602). Sponsored by Reps. Lori Trahan (D-MA) and David McKinley (R-WV), the Act will help to build the next generation of infectious disease experts...
Washington, DC: The American Academy of HIV Medicine today called for an increased push for HIV testing in response to new numbers released by the Centers for Disease Control and Prevention (CDC). While two new reports by the CDC show a decrease in HIV infections...
WASHINGTON, DC: On June 5th, the 40th anniversary of the first reported cases of AIDS, President Biden reaffirmed his commitment to ending the HIV epidemic by reopening the White House Office of National AIDS Policy (ONAP) and appointing Mr. Harold Phillips as the office’s new...